Monday, August 10, 2026 · Five AI analysts screened this index for stocks with the best shot at gaining +5% within 30 days
Optimistic Normal choppiness · VIX 15.2
Breadth is healthy outside of a sharp semiconductor/AI-hardware pullback (KLAC, AMD, LRCX, MU, ON, NXPI all down double digits over the past month) and mega-cap volatility in Tesla and Meta. Financials, industrials, healthcare diagnostics/biotech, steel and select retail names are pressing new highs with consistent 5-day and 30-day momentum, suggesting capital rotating into value/cyclical leadership.
Which of today's picks to actually take, and at what size, given what you are already holding. Each pick's own Suggested Allocation sizes it in isolation; this table applies the portfolio limits — at most 20 open positions and 60% of the portfolio committed in total. Run with --capital 25000 to see these sizes as order amounts rather than percentages.
| Rank | Stock | Action | Size | Entry → Target | Notes |
|---|---|---|---|---|---|
| #1 | WAT | SKIP | — | $411.76 → $433.90 stop $380.47 |
Position cap reached — 60 of 20 slots in use. |
| #2 | AMGN | SKIP | — | $412.72 → $434.64 stop $382.59 |
Position cap reached — 60 of 20 slots in use. |
| #3 | FAST | SKIP | — | $51.85 → $54.50 stop $48.22 |
Position cap reached — 60 of 20 slots in use. |
| #4 | PH | SKIP | — | $1,070.02 → $1,125.53 stop $992.98 |
Position cap reached — 60 of 20 slots in use. |
| #5 | PANW | SKIP | — | $378.29 → $397.20 stop $347.27 |
Position cap reached — 60 of 20 slots in use. |
Already open: NTRS (to Aug 13), BNY (to Aug 15), BNY (to Aug 16), USB (to Aug 16), USB (to Aug 18), USB (to Aug 19), VLO (to Aug 19), AFL (to Aug 19), BAC (to Aug 20), MTB (to Aug 20), STT (to Aug 20), CSX (to Aug 22) … and 48 more. Symbols you already hold were excluded from this run's candidates rather than re-picked.
Position-sizing guidance only — half-Kelly per pick, bounded by the limits above. Not personal investment advice.
Waters Corporation makes lab testing equipment used in pharmaceutical, food, and environmental science labs. Its shares have been climbing steadily and are outperforming the broader market, with technical readings showing strength without being extremely overbought. The main risk is a broader market pullback or a slowdown in lab-equipment demand that could stall the rally.
Why the AI likes it
What could go wrong
Calibrated probability: 73% (raw model estimate: 70%) — adjusted using the accuracy of past resolved picks.
Trade math
Suggested allocation is half-Kelly sizing guidance capped at 10% — not personal investment advice. Allocations are scaled to 85% of half-Kelly for the current market regime.
What each AI analyst estimated
Amgen is one of the world's largest biotech companies, selling a broad portfolio of drugs for bone disease, cancer, and other conditions. Its latest quarter showed profits surging 65% with growth spread across 22 different products, though a few older drugs are losing ground to cheaper biosimilar competitors, and the stock has already risen a lot recently, so some of the good news may be priced in already.
Why the AI likes it
What could go wrong
Calibrated probability: 73% (raw model estimate: 67%) — adjusted using the accuracy of past resolved picks.
Trade math
Suggested allocation is half-Kelly sizing guidance capped at 10% — not personal investment advice. Allocations are scaled to 85% of half-Kelly for the current market regime.
What each AI analyst estimated
Fastenal distributes nuts, bolts, and other industrial supplies to factories and construction companies. Its share price is in a strong, steady uptrend, beating the broader market, backed by a confirmed longer-term trend and no warning flags. The main risk is that industrial spending trends could soften, or the recent run-up could simply run out of steam.
Why the AI likes it
What could go wrong
Calibrated probability: 73% (raw model estimate: 63%) — adjusted using the accuracy of past resolved picks.
Trade math
Suggested allocation is half-Kelly sizing guidance capped at 10% — not personal investment advice. Allocations are scaled to 85% of half-Kelly for the current market regime.
What each AI analyst estimated
Parker-Hannifin makes motion and fluid-control components used in aerospace, industrial, and transportation equipment. Shares are in a strong, confirmed uptrend, outperforming the market, with healthy technical readings and no warning flags. The main risk is exposure to a broader industrial slowdown or the current rally simply losing steam after such a strong move.
Why the AI likes it
What could go wrong
Calibrated probability: 73% (raw model estimate: 64%) — adjusted using the accuracy of past resolved picks.
Trade math
Suggested allocation is half-Kelly sizing guidance capped at 10% — not personal investment advice. Allocations are scaled to 85% of half-Kelly for the current market regime.
What each AI analyst estimated
Palo Alto Networks sells cybersecurity software that protects companies from hackers. The stock has climbed steadily over the past month, is beating the overall market, and its momentum readings look healthy rather than overheated, alongside a confirmed uptrend. The main risk is that the company reports earnings in about three weeks, and any disappointment could quickly erase the recent gains.
Why the AI likes it
What could go wrong
Calibrated probability: 73% (raw model estimate: 67%) — adjusted using the accuracy of past resolved picks.
Trade math
Suggested allocation is half-Kelly sizing guidance capped at 10% — not personal investment advice. Allocations are scaled to 85% of half-Kelly for the current market regime.
What each AI analyst estimated
This report identifies stocks with an AI-assessed probability of gaining +5% within 30 calendar days (target exit by September 9, 2026). Picks are ranked by how many independent AI agents agreed — more agreement means higher conviction. The guide below tells you exactly how to act on them.
Step-by-Step Action Plan
Position Sizing by Conviction Tier
Size each position according to the coloured border on its pick card. Cap your total exposure across all picks from this report at 25% of your overall trading budget.
| Agents Agreeing | What It Means | Max Allocation Per Pick |
|---|---|---|
| 5/5 | Highest conviction — all five independent analytical checks passed | Up to 10% |
| 4/5 | Very high conviction — four of five independent checks aligned | Up to 8% |
| 3/5 | High conviction — three agents independently agreed | Up to 6% |
| 2/5 | Moderate conviction — two agents independently agreed | Up to 4% |
| 1 Agent | Speculative — solo pick, admitted only at Very High confidence | Up to 2% |
The Three Exit Rules
A plain-English guide to every figure shown on each pick card — what it means, how it is calculated, and what a good or bad value looks like.
Scout scanned 503 S&P 500 constituents and short-listed 28 candidates for deep analysis by the five analysts. Here is what happened to each one.
Checks 30-day price history for every candidate before making any selection. Requires positive period return and positive 5-day momentum as mandatory gates. Ranks picks by proximity to their period high and adjusts probability based on volume. Uses news only to rule out major negative catalysts.
Searches earnings results, analyst upgrades, and revenue trends before checking price data. Requires at least one verifiable fundamental catalyst — earnings beat, analyst upgrade, or revenue acceleration — within the last 60 days. Favours stocks with strong fundamentals trading below recent highs (value entry).
Hunts for specific events within the last 21 days: FDA approvals, major contract wins, product launches, earnings surprises, or significant analyst upgrades. Requires a positive price reaction confirming the market is recognising the catalyst. Also scans for upcoming events that could drive further gains.
Maps the macroeconomic regime (risk-on / risk-off / neutral) and identifies sectors benefiting from current conditions before looking at individual stocks. Only selects stocks from macro-aligned sectors with confirmed sector tailwinds. Adjusts for interest rate sensitivity and geopolitical factors.
Reviews the final picks after all four analysts agree and actively challenges each bull thesis. Searches for bearish technical signals, negative news, insider selling, and elevated short interest that the agreeing agents may have underweighted. Produces evidence-based counter-arguments shown on each pick card.
Pure-quant analyst: no news, no narrative, only numbers. Identifies mean-reversion setups from RSI extremes (<35) with momentum turning, Bollinger squeeze breakouts, and multi-factor quant scores using RSI, MACD, OBV, short interest, and insider transaction data. Counterbalances narrative bias across the four analyst agents.